Welcome!

News Feed Item

Trichotillomania Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Trichotillomania Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312348/Trichotillomania-Global-Clinical-Trials-Review-H2-2014.html

Trichotillomania Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Trichotillomania Global Clinical Trials Review, H2, 2014" provides data on the Trichotillomania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Trichotillomania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Trichotillomania. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Trichotillomania 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in North America 8
Top Countries Contributing to Clinical Trials in Middle East and Africa 9
Top Countries Contributing to Clinical Trials in Central and South America 10
Clinical Trials by G7 Countries: Proportion of Trichotillomania to Central Nervous System Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by E7 Countries: Proportion of Trichotillomania to Central Nervous System Clinical Trials 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Drugs 21
Clinical Trial Overview of Top Institutes / Government 22
National Institute of Mental Health 22
Clinical Trial Overview of National Institute of Mental Health 22
Massachusetts General Hospital 23
Clinical Trial Overview of Massachusetts General Hospital 23
University of Chicago 24
Clinical Trial Overview of University of Chicago 24
American University of Beirut Medical Center 25
Clinical Trial Overview of American University of Beirut Medical Center 25
Yale University 26
Clinical Trial Overview of Yale University 26
University of South Florida 27
Clinical Trial Overview of University of South Florida 27
University of Sao Paulo 28
Clinical Trial Overview of University of Sao Paulo 28
Hamilton Health Sciences 29
Clinical Trial Overview of Hamilton Health Sciences 29
University of Pennsylvania 30
Clinical Trial Overview of University of Pennsylvania 30
Stanford University 31
Clinical Trial Overview of Stanford University 31
Five Key Clinical Profiles 32
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 51
Contact Us 51
Disclaimer 51
Source 51

List of Tables
Trichotillomania Therapeutics, Global, Clinical Trials by Region, 2014* 6
Trichotillomania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Trichotillomania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 7
Trichotillomania Therapeutics Clinical Trials, North America, Top Countries, 2014* 8
Trichotillomania Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 9
Trichotillomania Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 10
Proportion of Trichotillomania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 11
Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 12
Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 13
Proportion of Trichotillomania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 14
Trichotillomania Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Trichotillomania Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Trichotillomania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Trichotillomania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Trichotillomania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Trichotillomania Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 20
Trichotillomania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 21
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 22
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 23
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014* 24
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by American University of Beirut Medical Center, 2014* 25
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 26
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014* 27
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 28
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 29
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 30
Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 31

List of Figures
Trichotillomania Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Trichotillomania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Trichotillomania Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 8
Proportion of Trichotillomania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 11
Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 12
Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 13
Proportion of Trichotillomania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 14
Trichotillomania Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Trichotillomania Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Trichotillomania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Trichotillomania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Trichotillomania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Trichotillomania Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 20
GlobalData Methodology 50


Read the full report:
Trichotillomania Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312348/Trichotillomania-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Tintri VM-aware storage is the simplest for virtualized applications and cloud. Organizations including GE, Toyota, United Healthcare, NASA and 6 of the Fortune 15 have said "No to LUNs." With Tintri they manage only virtual machines, in a fraction of the footprint and at far lower cost than conventional storage. Tintri offers the choice of all-flash or hybrid-flash platform, converged or stand-alone structure and any hypervisor. Rather than obsess with storage, leaders focus on the business app...
Both SaaS vendors and SaaS buyers are going “all-in” to hyperscale IaaS platforms such as AWS, which is disrupting the SaaS value proposition. Why should the enterprise SaaS consumer pay for the SaaS service if their data is resident in adjacent AWS S3 buckets? If both SaaS sellers and buyers are using the same cloud tools, automation and pay-per-transaction model offered by IaaS platforms, then why not host the “shrink-wrapped” software in the customers’ cloud? Further, serverless computing, cl...
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Why do your mobile transformations need to happen today? Mobile is the strategy that enterprise transformation centers on to drive customer engagement. In his general session at @ThingsExpo, Roger Woods, Director, Mobile Product & Strategy – Adobe Marketing Cloud, covered key IoT and mobile trends that are forcing mobile transformation, key components of a solid mobile strategy and explored how brands are effectively driving mobile change throughout the enterprise.
In his General Session at 17th Cloud Expo, Bruce Swann, Senior Product Marketing Manager for Adobe Campaign, explored the key ingredients of cross-channel marketing in a digital world. Learn how the Adobe Marketing Cloud can help marketers embrace opportunities for personalized, relevant and real-time customer engagement across offline (direct mail, point of sale, call center) and digital (email, website, SMS, mobile apps, social networks, connected objects).
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at 20th Cloud Expo, Ed Featherston, director/senior enterprise architect at Collaborative Consulting, will discuss the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
Information technology (IT) advances are transforming the way we innovate in business, thereby disrupting the old guard and their predictable status-quo. It’s creating global market turbulence. Industries are converging, and new opportunities and threats are emerging, like never before. So, how are savvy chief information officers (CIOs) leading this transition? Back in 2015, the IBM Institute for Business Value conducted a market study that included the findings from over 1,800 CIO interviews ...
"Matrix is an ambitious open standard and implementation that's set up to break down the fragmentation problems that exist in IP messaging and VoIP communication," explained John Woolf, Technical Evangelist at Matrix, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Some people worry that OpenStack is more flash then substance; however, for many customers this could not be farther from the truth. No other technology equalizes the playing field between vendors while giving your internal teams better access than ever to infrastructure when they need it. In his session at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will talk through some real-world OpenStack deployments and look into the ways this can benefit customers of all sizes....
"A lot of times people will come to us and have a very diverse set of requirements or very customized need and we'll help them to implement it in a fashion that you can't just buy off of the shelf," explained Nick Rose, CTO of Enzu, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infrastructure through automation. Ayehu solutions have been deployed by major enterprises worldwide, and currently, support thousands of IT processes across the globe. The company has offices in New York, California, and Isr...